Company · CIK 0000861838
Aceragen, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- 8-KCurrent report0001104659-23-092550 · 303.9 KBSEC(opens sec.gov)
- SC 13D/AAceragen, Inc.0001193125-23-202969 · 132.2 KBSEC(opens sec.gov)
- 8-KCurrent report0001104659-23-083038 · 197.5 KBSEC(opens sec.gov)
- SC 13D/AAceragen, Inc.0001193125-23-187666 · 115.3 KBSEC(opens sec.gov)
- 8-KCurrent report0001104659-23-080018 · 716.2 KBSEC(opens sec.gov)
- 10-QQuarterly update0001558370-23-011603 · 7.7 MBSEC(opens sec.gov)
- 8-KCurrent report0001104659-23-066071 · 243.7 KBSEC(opens sec.gov)
- 8-KCurrent report0001104659-23-055819 · 213.3 KBSEC(opens sec.gov)
- 10-KAnnual report0001558370-23-005875 · 13.1 MBSEC(opens sec.gov)
- SC 13D/AAceragen, Inc.0001193125-23-096589 · 106.9 KBSEC(opens sec.gov)
Insiders
- 14159, L.P.Director, 10% Owner
- 667, L.P.Director, 10% Owner
- Aceragen, Inc.Insider
- Arbeit Robert D.VP Clinical Development
- Arcudi III Louis JChief Financial Officer
- Baker Biotech Capital (GP), LLC10% Owner
- Baker Bros. Advisors (GP) LLC10% Owner
- BAKER BROS. ADVISORS LP10% Owner
- Baker Bros. Capital (GP), LLC10% Owner
- Baker Brothers Life Sciences LPDirector, 10% Owner
Tickers
No tickers on record.
Addresses
business
505 EAGLEVIEW BOULEVARD SUITE 212
EXTON, PA, 19341
mailing
505 EAGLEVIEW BOULEVARD SUITE 212
EXTON, PA, 19341
Former names
- IDERA PHARMACEUTICALS, INC.2023-01-13
- HYBRIDON INC2005-09-02
Same industry
Related Biological Products, (No Diagnostic Substances) companies
- TBIO-TECHNE CorpTECH
- AAERIE PHARMACEUTICALS INC
- CCellular Biomedicine Group, Inc.
- TTourmaline Bio, Inc.TRML
- NNKGen Biotech, Inc.
- TTevogen Inc.TVGN
- AAttovia Therapeutics, Inc.ATTO
View all Biological Products, (No Diagnostic Substances) companies